Prevention of Incisional Hernia With Biosynthetic Mesh at the Site of Temporary Ileostomy Closure (PRINCESS) (PRINCESS)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05400083 |
Recruitment Status :
Recruiting
First Posted : June 1, 2022
Last Update Posted : June 3, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Prophylactic mesh reinforcement of the abdominal wall at the site of temporary ileostomy closure is effective in preventing postoperative incisional hernia.
This prospective, multicenter, observational study will evaluate performance of Phasix biosynthetic mesh when used to reinforce fascial closure .
Condition or disease |
---|
Incisional Hernia |
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 203 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 2 Years |
Official Title: | Prevention of Incisional Hernia With Biosynthetic Mesh at the Site of Temporary Ileostomy Closure |
Actual Study Start Date : | May 17, 2021 |
Estimated Primary Completion Date : | May 2023 |
Estimated Study Completion Date : | May 2024 |
- Incisional hernia rate [ Time Frame: at 24 months ]CT scan or Ultrasound as imaging to detect incisional hernia
- Early and Long-term Complication Rates [ Time Frame: after surgery to 24 months ]Clavien-Dindo classification
- Postoperative pain [ Time Frame: after surgery to 24 months ]Visual analogue scales (VAS) Range: 1-100. Higher score correlates with more pain
- Quality of life by Carolinas Comfort Scale (CCS) and Euro-Qol 5D-5L questionnaires [ Time Frame: after surgery to 24 months ]CCS - Range: 0-115. Higher score correlates with worse outcome
- Budget Impact Analysis [ Time Frame: after surgery to 24 months ]Healthcare Cost Analysis including direct costs (fixed and variable)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Subjects will be informed about the study, and will have read; understood and signed the informed consent
- Subjects of either gender that are at least the age of 18 years
- Subjects will be undergoing ileostomy reversal with retromuscular placement technique of the Phasix biosynthetic mesh reinforcement
Exclusion Criteria:
- Subjects who, in the surgeon's opinion, would have a difficult time comprehending or complying with the requirements of the study
- Subjects with parastomal hernia or midline incisional hernia
- Subjects who required midline laparotomy during ileostomy reversal
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05400083
Contact: Umberto Bracale, Prof | +390817462544 | umbertobracale@gmail.com |
Italy | |
Minimally Invasive General and Oncologic Surgery Unit - Univesity of Naples Federico II | Recruiting |
Naples, Italy, 80131 | |
Contact: Umberto Bracale, Prof +390817462544 | |
Sub-Investigator: Roberto Peltrini, Dr |
Responsible Party: | Umberto Bracale, Prof., Federico II University |
ClinicalTrials.gov Identifier: | NCT05400083 |
Other Study ID Numbers: |
471/20 |
First Posted: | June 1, 2022 Key Record Dates |
Last Update Posted: | June 3, 2022 |
Last Verified: | May 2022 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Hernia Incisional Hernia Pathological Conditions, Anatomical Postoperative Complications Pathologic Processes |